Epidemiology of mucormycosis in India

Current Fungal Infection Reports

Volumn 7, Issue 4, 2013, Pages 287-292

  Chakrabarti, Arunaloke ^a   Dhaliwal, Manpreet ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Apophysomyces elegans; Computational model; Diabetes; Epidemiology; Hematology; Immunocompetent host; Mucoraceous fungi; Mucormycosis; Nosocomial; Renal disease; Rhizopus; Transplant; Zygomycosis

Indexed keywords

APOPHYSOMYCES ELEGANS; ARTICLE; CUNNINGHAMELLA BERTHOLLETIAE; DEBRIDEMENT; DIABETES MELLITUS; FUNGUS; HEALTH CARE; HEALTH CARE FACILITY; HISTOPATHOLOGY; HUMAN; INCIDENCE; INDIA; INTRAVENOUS DRUG ABUSE; KETOACIDOSIS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MACROPHAGE; MORTALITY; MUCORMYCOSIS; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; RHIZOPUS ORYZAE; SKIN INFECTION; SYSTEMIC MYCOSIS; WOUND INFECTION;

EID: 84890569457     PISSN: 19363761     EISSN: 1936377X     Source Type: Journal    
DOI: 10.1007/s12281-013-0152-z     Document Type: Article

References (58)

1. •• Petrikkos G, Skiada A, Lortholary O, et al. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54 Suppl 1:S23-34. This review details the emerging epidemiology and the clinical forms of mucormycosis and highlights the difference of epidemiology between the two regions.
2. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634-53.
3. Sugar AM. Agents of mucormycosis and related species. In: Mandell G, Bennett J, Dolin R, editors. Principles and practices of infectious diseases. 4th ed. New York: Churchill Livingstone; 1995. p. 2311-21.
4. •Rammaert B, Lanternier F, Zahar JR, et al. Healthcare-associated mucormycosis. Clin Infect Dis. 2012;54 Suppl 1:S44-54. This paper documents all healthcare procedure associated mucormycosis, which is an emerging problem in hospitals.
5. Chakrabarti A, Das A, Mandal J, et al. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol. 2006;44:335-42.
6. Chakrabarti A, Chatterjee SS, Das A, et al. Invasive zygomycosis in India: experience in a tertiary care hospital. Postgrad Med J. 2009;85:573-81.
7. Al-Ajam MR, Bizri AR, Mokhbat J, et al. Mucormycosis in the Eastern Mediterranean: a seasonal disease. Epidemiol Infect. 2006;134:341-6.
8. Funada H, Matsuda T. Pulmonary mucormycosis in a hematology ward. Intern Med. 1996;35:540-4.
9. Shpitzer T, Keller N, Wolf M, et al. Seasonal variations in rhino-cerebral Mucor infection. Ann Otol Rhinol Laryngol. 2005;114:695-8.
10. Nithyanandam S, Jacob MS, Battu RR, et al. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol. 2003;51:231-6.
11. Chakrabarti A, Das A, Sharma A, et al. Ten years' experience in zygomycosis at a tertiary care centre in India. J Infect. 2001;42:261-6.
12. •• Marak RS, Misra R, Ansari MS, et al. Successful medical management of renal zygomycosis: a summary of two cases and a review of the Indian literature. Med Mycol. 2010;48:1088-95. This review deals with isolated renal mucormycosis problem, its epidemiology, diagnosis and management.
13. Diwakar A, Dewan RK, Chowdhary A, et al. Zygomycosis-a case report and overview of the disease in India. Mycoses. 2007;50:247-54.
14. Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004;10 Suppl 1:31-47.
15. Chakravarti A, Bhargava R, Bhattacharya S. Cutaneous mucormycosis of nose and facial region in children: a case series. Int J Pediatr Otorhinolaryngol. 2013;77:869-72.
16. Chander J, Kaur J, Attri A, et al. Primary cutaneous zygomycosis from a tertiary care centre in north-west India. Indian J Med Res. 2010;131:765-70.
17. Ramesh V, Ramam M, Capoor MR, et al. Subcutaneous zygomycosis: report of 10 cases from two institutions in North India. J Eur Acad Dermatol Venereol. 2010;24:1220-5.
18. Bhansali A, Bhadada S, Sharma A, et al. Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes. Postgrad Med J. 2004;80:670-4.
19. Godara SM, Kute VB, Goplani KR, et al. Mucormycosis in renal transplant recipients: predictors and outcome. Saudi J Kidney Dis Transpl. 2011;22:751-6.
20. Patra S, Vij M, Chirla DK, et al. Unsuspected invasive neonatal gastrointestinal mucormycosis: a clinicopathological study of six cases from a tertiary care hospital. J Indian Assoc Pediatr Surg. 2012;17:153-6.
21. Yamazaki T, Kume H, Murase S, et al. Epidemiology of visceral mycoses: analysis of data in annual of the pathological autopsy cases in Japan. J Clin Microbiol. 1999;37:1732-8.
22. Chamilos G, Luna M, Lewis RE, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica. 2006;91:986-9.
23. • Chakrabarti A, Sood P, Denning D. Estimating fungal infection burden in India using computational models: Mucormycosis burden as a case study [Poster number 1044]. Presented at the 23rd ECCMID conference. Berlin, Germany; April 27-30, 2013. This poster elucidates mucormycosis burden in India using a contextual computational model.
24. Bitar D, Van Cauteren D, Lanternier F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis. 2009;15:1395-401.
25. Kontoyiannis DP, Lionakis MS, Lewis RE, et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis. 2005;191:1350-60.
26. Husain S, Alexander BD, Munoz P, et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis. 2003;37:221-9.
27. Stelzmueller I, Lass-Floerl C, Geltner C, et al. Zygomycosis and other rare filamentous fungal infections in solid organ transplant recipients. Transpl Int. 2008;21:534-46.
28. • Skiada A, Pagano L, Groll A, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011;17:1859-67. This paper highlights the epidemiology of mucormycosis in Europe.
29. Saegeman V, Maertens J, Meersseman W, et al. Increasing incidence of mucormycosis in University Hospital, Belgium. Emerg Infect Dis. 2010;16:1456-8.
30. Pagano L, Valentini CG, Posteraro B, et al. Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology). J Chemother. 2009;21:322-9.
31. Kontoyiannis DP. Decrease in the number of reported cases of zygomycosis among patients with diabetes mellitus: a hypothesis. Clin Infect Dis. 2007;44:1089-90.
32. The IDF Diabetes Atlas. 4th ed. Brussels: International Diabetes Federation; 2009.
33. Ingram CW, Sennesh J, Cooper JN, et al. Disseminated zygomycosis: report of four cases and review. Rev Infect Dis. 1989;11:741-54.
34. Weng DE, Wilson WH, Little R, et al. Successful medical management of isolated renal zygomycosis: case report and review. Clin Infect Dis. 1998;26:601-5.
35. Chugh KS, Sakhuja V, Gupta KL, et al. Renal mucormycosis: computerized tomographic findings and their diagnostic significance. Am J Kidney Dis. 1993;22:393-7.
36. Gupta KL, Radotra BD, Sakhuja V, et al. Mucormycosis in patients with renal failure. Ren Fail. 1989;11:195-9.
37. Gupta KL, Joshi K, Sud K, et al. Renal zygomycosis: an under-diagnosed cause of acute renal failure. Nephrol Dial Transplant. 1999;14:2720-5.
38. Chakrabarti A, Ghosh A, Prasad GS, et al. Apophysomyces elegans: an emerging zygomycete in India. J Clin Microbiol. 2003;41:783-8.
39. Singh SK, Wadhwa P, Sakhuja V. Isolated bilateral renal mucormycosis. Urology. 2004;63:979-80.
40. Sharma R, Shivanand G, Kumar R, et al. Isolated renal mucormycosis: an unusual cause of acute renal infarction in a boy with aplastic anaemia. Br J Radiol. 2006;79:e19-21.
41. Thomas AJ, Shah S, Mathews MS, et al. Apophysomyces elegans - renal mucormycosis in a healthy host: a case report from south India. Indian J Med Microbiol. 2008;26:269-71.
42. Dhua AK, Sinha S, Sarin YK, et al. Isolated mucormycosis in a post-pyeloplasty kidney in an immuno-competent child. J Indian Assoc Pediatr Surg. 2012;17:132-4.
43. Khandelwal D, Gadodia A, Sood R, et al. Disseminated zygomycosis with renal involvement simulating malignancy in a diabetic patient. Indian J Urol. 2012;28:347-9.
44. Jianhong L, Xianliang H, Xuewu J. Isolated renal mucormycosis in children. J Urol. 2004;171:387-8.
45. Lin CY, Lee SC, Lin CC, et al. Isolated fatal renal mucormycosis in a patient with chronic obstructive pulmonary disease and tuberculosis. Int J Clin Pract. 2003;57:916-8.
46. Yu J, Li RY. Primary renal zygomycosis due to Rhizopus oryzae. Med Mycol. 2006;44:461-6.
47. Gupta KL, Khullar DK, Behera D, et al. Pulmonary mucormycosis presenting as fatal massive haemoptysis in a renal transplant recipient. Nephrol Dial Transplant. 1998;13:3258-60.
48. Gupta K, Nada R, Joshi K, et al. Can ascending infection from bladder serve as the portal of entry for primary renal zygomycosis? Mycopathologia. 2010;170:357-60.
49. Misra PC, Srivastava KJ, Lata K. Apophysomyces, a new genus of the Mucorales. Mycotaxon. 1979;8:377-82.
50. Meis JF, Chakrabarti A. Changing epidemiology of an emerging infection: zygomycosis. Clin Microbiol Infect. 2009;15 Suppl 5:10-4.
51. Cooter RD, Lim IS, Ellis DH, et al. Burn wound zygomycosis caused by Apophysomyces elegans. J Clin Microbiol. 1990;28:2151-3.
52. •• Chakrabarti A, Shivaprakash MR, Curfs-Breuker I, et al. Apophysomyces elegans: epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility pattern. J Clin Microbiol. 2010;48:4580-5. This is a detailed study on the strain typing, in-vitro antifungal susceptibility and clinical manifestations of the diseases caused by Apophysomyces elegans in India.
53. Alvarez E, Stchigel AM, Cano J, et al. Molecular phylogenetic diversity of the emerging mucoralean fungus Apophysomyces: proposal of three new species. Rev Iberoam Micol. 2010;27:80-9.
54. Padhye AA, Ajello L. Simple method of inducing sporulation by Apophysomyces elegans and Saksenaea vasiformis. J Clin Microbiol. 1988;26:1861-3.
55. Chakrabarti A, Marak RS, Shivaprakash MR, et al. Cavitary pulmonary zygomycosis caused by Rhizopus homothallicus. J Clin Microbiol. 2010;48:1965-9.
56. Hemashettar BM, Patil RN, O'Donnell K, et al. Chronic rhinofacial mucormycosis caused by Mucor irregularis (Rhizomucor variabilis) in India. J Clin Microbiol. 2011;49:2372-5.
57. Sivakumar S, Mathews MS, George B. Cunninghamella pneumonia in postbone marrow transplant patient: first case report from India. Mycoses. 2005;48:360-2.
58. Xess I, Mohapatra S, Shivaprakash MR, et al. Evidence implicating Thamnostylum lucknowense as an etiological agent of rhino-orbital mucormycosis. J Clin Microbiol. 2012;50:1491-4.